Cellectis Logo.png
Cellectis to Present Preclinical Data on UCARTMESO Supporting Anti-Tumor Activity at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
12 oct. 2021 16h35 HE | Cellectis Inc.
NEW YORK, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing platform company with clinical-stage immuno-oncology programs using...
Cellectis Logo.png
Monthly information on share capital and company voting rights
11 oct. 2021 16h30 HE | Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) NEW YORK, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal...
Retrotope Reports Data from Phase 2/3 Clinical Trial of RT001 and Concurrent Natural History Study in Patients with Infantile Neuroaxonal Dystrophy (INAD)
06 oct. 2021 07h00 HE | Retrotope
Treatment with RT001 Results in Statistically Significant Improvements in Overall Survival and Progression Free Survival for INAD Patients as Compared to Control Benefits Supported by Totality of...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Reports Inducement Grants For New Staff
06 oct. 2021 07h00 HE | Recro Pharma, Inc.
EXTON, Penn. and SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
28 sept. 2021 07h00 HE | Managed Markets Insight & Technology, LLC
Yardley, PA, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT) and Evaluate (a Welsh, Carson, Anderson & Stowe and Hg portfolio company)—which joined forces last...
lsif-logo-default (1).png
Alpha Cognition to Webcast Live at Life Sciences Investor Forum September 16th
09 sept. 2021 08h35 HE | Life Sciences Investor Forum
VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Alpha Cognition, Inc. (TSX-V: ACOG)(OTCQB: ACOGF)(“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro to Host Webcast to Discuss Acquisition of San Diego-Based IRISYS
17 août 2021 07h00 HE | Recro Pharma, Inc.
Acquisition Expands Recro’s Global Customer Base and Service Offerings, Creates Bi-Coastal CDMO, Diversifies Pipeline and Revenue Sources, and Provides Additional Pathway for Continued Growth Webcast...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Announces Acquisition of San Diego-based IRISYS, Creating Bi-Coastal, Full Service CDMO
13 août 2021 08h50 HE | Recro Pharma, Inc.
Combination of Synergistic Organizations Results in Broad CDMO Service with Capabilities Spanning from Pre-IND Development to Commercial Manufacturing and Packaging for Wide Range of Dosage Forms ...
Sunshine Biopharma Logo
Sunshine Biopharma’s Coronavirus Treatment Anticipated to be Effective Against Delta and the Other Variants of Concern
12 août 2021 09h00 HE | Sunshine Biopharma Inc.
MONTREAL, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC Pink: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Announces Entry Into Letter of Intent for Acquisition of a Full Service CDMO
10 août 2021 07h00 HE | Recro Pharma, Inc.
EXTON, Pa., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...